Expertises
Medicine and Dentistry
- Patient
- Drug-Eluting Stent
- Stent
- Percutaneous Coronary Intervention
- Lesion
- Inpatient
- Myocardial Infarction
Pharmacology, Toxicology and Pharmaceutical Science
- Drug
Organisaties
Nevenwerkzaamheden
- Medisch Spectrum Twentemedical specialist
- Medisch Spectrum Twentemedisch specialist
- Medisch Spectrum Twentecardiologist, interventional cardiologist
- Medisch Spectrum Twentemedisch specialist
Publicaties
2025
Percutaneous coronary intervention in patients with polyvascular or premature atherosclerosis (2025)[Thesis › PhD Thesis - Research external, graduation UT]. University of Twente. Pinxterhuis, T. H.https://doi.org/10.3990/1.9789036569002Elderly patients treated with Onyx versus Orsiro drug-eluting coronary stents in a randomized clinical trial with long-term follow-up (2025)Clinical research in cardiology, 114(12), 1681-1691. Article e012438. van Vliet, D., Ploumen, E. H., Pinxterhuis, T. H., Doggen, C. J. M., Aminian, A., Schotborgh, C. E., Danse, P. W., Roguin, A., Anthonio, R. L., Benit, E., Kok, M. M., Linssen, G. C. M. & von Birgelen, C.https://doi.org/10.1007/s00392-025-02622-7Assessing long-term temporal changes in myocardial infarction treatment and outcomes: Chances and challenges (2025)The Lancet Regional Health - Europe, 58. Article 101473. von Birgelen, C. & van Vliet, D.https://doi.org/10.1016/j.lanepe.2025.101473Complex All-comers and Patients with Diabetes and Prediabetes Treated with Xience Sierra Everolimus-eluting Stents: COASTLINE High-Risk (2025)European Heart Journal Open, 5(6). Article oeaf140. van Vliet, D., Ploumen, E. H., Pinxterhuis, T. H., Buiten, R. A., Aminian, A., Schotborgh, C. E., Anthonio, R. L., Zocca, P., Hartmann, M., Stoel, M. G., de Man, F. H. A. F., Linssen, G. C. M., Doggen, C. J. M., van der Heijden, L. C., Kok, M. M. & von Birgelen, C.https://doi.org/10.1093/ehjopen/oeaf140Clockwise aortic root rotation in patients with tetralogy of fallot assessed with cardiovascular magnetic resonance imaging (2025)International journal of cardiovascular imaging, 41(8), 1497-1503. Voortman, M., van Es, J., von Birgelen, C., Ploumen, E. H., Doggen, C. J. M. & Wagenaar, L. J.https://doi.org/10.1007/s10554-025-03438-2Impact of diabetes on three-year outcome after coronary stenting in patients with polyvascular atherosclerotic disease – a secondary analysis of the randomized TWENTE trials (2025)IJC Heart and Vasculature, 59. Article 101741. van Vliet, D., Pinxterhuis, T. H., Ploumen, E. H., Kok, M. M., Buiten, R. A., Zocca, P., Roguin, A., Schotborgh, C. E., Anthonio, R. L., Danse, P. W., Benit, E., Aminian, A., Doggen, C. J. M. & von Birgelen, C.https://doi.org/10.1016/j.ijcha.2025.101741Impact of elevated lipoprotein(a) on epicardial coronary flow conductance and endoluminal atherosclerotic disease distribution (2025)Cardiovascular Revascularization Medicine (E-pub ahead of print/First online). Renkens, M. P. L., Tsai, T.-Y., Revaiah, P. C., Kageyama, S., Reiber, J. H. C., de Winter, R. J., Grundeken, M., Nurmohamed, N. S., Stroes, E., Garg, S., von Birgelen, C., Hofma, S., Alkhalil, M., Rosseel, L., Sharif, F., Smits, P. C., Baumbach, A., Onuma, Y., Wykrzykowska, J. J. & Serruys, P. W.https://doi.org/10.1016/j.carrev.2025.07.003Preferred Treatment and Expected Risk in Coronary Intervention Patients With Peripheral Arterial Disease: Cardiologists’ Views Versus Trials Data (2025)CJC Open, 7(6), 799-806. Pinxterhuis, T. H., von Birgelen, C., Ploumen, E. H., van Vliet, D., Kok, M. M., Buiten, R. A., van der Heijden, L. C., Zocca, P. & Doggen, C. J. M.https://doi.org/10.1016/j.cjco.2025.03.018Validation of the Zwolle Risk Score in STEMI Patients Undergoing Primary PCI: Insights from the ISCAS-STEMI COVID-19 Registry (2025)Current Vascular Pharmacology, 24(1), 68-75. De Luca, G., Algowhary, M., Uguz, B., Oliveira, D. C., Ganyukov, V., Zimbakov, Z., Cercek, M., Jensen, L. O., LOH, P. H., Calmac, L., Roura i Ferrer, G., Quadros, A., Malewski, M., Di Uccio, F. S., von Birgelen, C., Versaci, F., Ten Berg, J., Casella, G., Wong Sung Lung, A., … Verdoia, M.https://doi.org/10.2174/0115701611335913250408214530Final kissing balloon dilatation in patients with coronary bifurcation lesions treated with an upfront provisional stenting strategy (2025)EuroIntervention, 21(6), e318-e328. De Filippo, O., Kang, J., Bruno, F., Song, Y. B., Campagnuolo, S., Choi, K. H., Pinxterhuis, T. H., Kim, H. K., Mattesini, A., Cho, Y. K., Piccolo, R., Lee, H. J., Wańha, W., Cortese, B., Han, S. H., Perl, L., Hur, S. H., Tuttolomondo, D., Iannaccone, M., … D’Ascenzo, F.https://doi.org/10.4244/EIJ-D-24-00471Rationale and design of the STOP-IMH randomised trial: Safety of ticagrelor monotherapy after primary percutaneous coronary intervention for ST-elevation myocardial infarction and the effect on intramyocardial haemorrhage (2025)IJC Heart and Vasculature, 56. Article 101564. Woelders, E. C. I., Yosofi, B., Peeters, D. A. M., Konijnenberg, L. S. F., von Birgelen, C., van Rees, J. B., van den Oord, S. C. H., Heestermans, A. A. C. M., Claessen, B. E. P. M., van Royen, N., van Geuns, R. J. M., Nijveldt, R. & Damman, P.https://doi.org/10.1016/j.ijcha.2024.101564Cost-Effectiveness of Three Different New-Generation Drug-Eluting Stents in the Randomised BIO-RESORT Trial at 3 Years (2025)PharmacoEconomics - Open, 9(1), 137–145. Article e000064. Ploumen, E. H., Oude Wolcherink, M. J., Buiten, R. A., Pinxterhuis, T. H., Doggen, C. J. M., Schotborgh, C. E., Danse, P. W., Scholte, M., van Houwelingen, K. G., Zocca, P., Pouwels, X. G. L. V. & von Birgelen, C.https://doi.org/10.1007/s41669-024-00539-xSex and age-specific 10-year mortality after coronary stenting: an analysis of two randomized trials (2025)European Heart Journal Open, 5(1). Article oeaf006. Pinxterhuis, T. H., Ploumen, E. H., Doggen, C. J. M., van Vliet, D., Kok, M. M., Zocca, P., Hartmann, M., van Houwelingen, K. G., Stoel, M. G., de Man, F. H. A. F., Linssen, G. C. M. & von Birgelen, C.https://doi.org/10.1093/ehjopen/oeaf006
2024
Clinical outcome after bleeding events following coronary stenting in patients with and without comorbid peripheral arterial disease (2024)Cardiovascular Intervention and Therapeutics. Article e001004 (E-pub ahead of print/First online). Pinxterhuis, T. H., Ploumen, E. H., Kok, M. M., Schotborgh, C. E., Anthonio, R. L., Roguin, A., Danse, P. W., Benit, E., Aminian, A., Hartmann, M., Linssen, G. C. M., Geelkerken, R. H., Doggen, C. J. M. & von Birgelen, C.https://doi.org/10.1007/s12928-024-01073-7Cost-effectiveness analysis of transthoracic echocardiographic assessment in patients with ischemic stroke or TIA of undetermined cause (2024)Journal of Stroke & Cerebrovascular Diseases, 33(12). Article 108013. van der Maten, G., Pouwels, X. G. L. V., Meijs, M. F. L., von Birgelen, C., den Hertog, H. M. & Koffijberg, H.https://doi.org/10.1016/j.jstrokecerebrovasdis.2024.108013Treatment of in-stent restenosis with ultrathin-strut versus thin-strut drug-eluting stents or drug-eluting balloons: a multicentre registry (2024)EuroIntervention, 20(21), e1340-e1354. De Filippo, O., Wańha, W., Sanavia, T., Januszek, R., Giacobbe, F., Campo, G., Pinxterhuis, T. H., Capodanno, D., Tomasiewicz, B., Iannaccone, M., Leone, A., Wolny, R., Bruno, F., Patti, G., Musumeci, G., Liccardo, G., Verardi, R., Roubin, S. R., Tarantini, G., … D'Ascenzo, F.https://doi.org/10.4244/EIJ-D-24-00491Final 5-year report of BIONYX comparing the thin-composite wire-strut zotarolimus-eluting stent versus ultrathin-strut sirolimus-eluting stent (2024)Catheterization and cardiovascular interventions, 104(1), 1-9. van Vliet, D., Ploumen, E. H., Pinxterhuis, T. H., Buiten, R. A., Aminian, A., Schotborgh, C. E., Danse, P. W., Roguin, A., Anthonio, R. L., Benit, E., Zocca, P., Doggen, C. J. M. & von Birgelen, C.https://doi.org/10.1002/ccd.31067The impact of patient-reported frailty on cardiovascular outcomes in elderly patients after non-ST-acute coronary syndrome (2024)International journal of cardiology, 405. Article 131940. van den Broek, W. W. A., Gimbel, M. E., Hermanides, R. S., Runnett, C., Storey, R. F., Knaapen, P., Emans, M. E., Oemrawsingh, R. M., Cooke, J., Galasko, G., Walhout, R., Stoel, M. G., von Birgelen, C., van Bergen, P. F. M. M., Brinckman, S. L., Aksoy, I., Liem, A., van't Hof, A. W. J., Jukema, J. W., … ten Berg, J. M.https://doi.org/10.1016/j.ijcard.2024.131940Ethnic minorities treated with new-generation drug-eluting coronary stents in two European randomised clinical trials (2024)Netherlands heart journal, 32(6), 254-261. Ploumen, E. H., Semedo, E., Doggen, C. J. M., Schotborgh, C. E., Anthonio, R. L., Danse, P. W., Benit, E., Aminian, A., Stoel, M. G., Hartmann, M., van Houwelingen, K. G., Scholte, M., Roguin, A., Linssen, G. C. M., Zocca, P. & von Birgelen, C.https://doi.org/10.1007/s12471-024-01873-9Ten-year mortality after treating obstructive coronary atherosclerosis with contemporary stents in patients with or without concomitant peripheral arterial disease (2024)Atherosclerosis, 392. Article 117488. Pinxterhuis, T. H., Ploumen, E. H., van Vliet, D., van Houwelingen, K. G., Stoel, M. G., de Man, F. H., Hartmann, M., Zocca, P., Linssen, G. C., Geelkerken, R. H., Doggen, C. J. & von Birgelen, C.https://doi.org/10.1016/j.atherosclerosis.2024.117488Intra- and interobserver reliability in measuring aortic root rotation with cardiac magnetic resonance imaging (2024)Cardiovascular diagnosis and therapy, 14(2), 264-271. Voortman, M., Fitski, W., van Es, J., Doggen, C. J. M., Plonek, T., von Birgelen, C. & Wagenaar, L. J.https://doi.org/10.21037/cdt-23-384Impact of the number of modifiable risk factors on clinical outcomes after percutaneous coronary intervention: An analysis from the e-Ultimaster registry (2024)IJC Heart and Vasculature, 51. Article 101370. Kobo, O., Levi, Y., Abu-Fanne, R., von Birgelen, C., Guedes, A., Aminian, A., Laanmets, P., Dewilde, W., Witkowski, A., Monségu, J., Iñiguez, A., Halabi, M., Mamas, M. A. & Roguin, A.https://doi.org/10.1016/j.ijcha.2024.101370Invasiveness of previous treatment for peripheral arterial disease and risk of adverse cardiac events after coronary stenting (2024)Cardiovascular Intervention and Therapeutics, 39(2), 173-182. Pinxterhuis, T. H., von Birgelen, C., Geelkerken, R. H., Doggen, C. J. M., Menting, T. P., van Houwelingen, K. G., Linssen, G. C. M. & Ploumen, E. H.https://doi.org/10.1007/s12928-024-00986-7Routine transthoracic echocardiography in ischaemic stroke or transient ischaemic attack of undetermined cause: a prospective multicentre study (2024)Netherlands heart journal, 32(2), 91-98. van der Maten, G., Meijs, M. F. L., Timmer, J. R., Brouwers, P. J. A. M., von Birgelen, C., Coutinho, J. M., Bouma, B. J., Kerkhoff, H., Helming, A. M., van Tuijl, J. H., van der Meer, N. A., Saxena, R., Ebink, C., van der Palen, J. & den Hertog, H. M.https://doi.org/10.1007/s12471-023-01819-7Drug-coated balloons as a first choice for patients with de novo lesions: pros and cons (2024)EuroIntervention, 20(2), e120-e122. Colombo, A., Leone, P. P., Ploumen, E. H. & von Birgelen, C.https://doi.org/10.4244/EIJ-E-23-00034
Overige bijdragen
Publicaties in wetenschappelijke tijdschriften:
Op de homepage van PubMed.gov (https://www.ncbi.nlm.nih.gov/pubmed/) via de zoekterm: von Birgelen C[AU] , of via de directe link: https://www.ncbi.nlm.nih.gov/pubmed/?term=von+Birgelen+C%5BAU%5D .
Promovendi aan de Universiteit Twente
M.M. Kok. Percutaneous coronary interventions from various perspectives. Ph.D. (cum laude), 13-12-2018. Promotor: von Birgelen C.
L.C. van der Heijden. Second-generation drug-eluting stents and beyond. Ph.D., 06-12-2017. Promotor: von Birgelen C.
J.J. Kandhai-Ragunath. Peripheral endothelial function after ST-segment elevation myocardial infarction. Ph.D., 06-12-2017. Promotor: von Birgelen C.
M.K. Lam. Lesion morphology, vessel anatomy and the outcome of coronary stenting: Insight from the TWENTE trials. Ph.D., 17-06-2015. Promotors: von Birgelen C. and IJzerman M.J.
H. Sen. Drug-eluting stent use in patients with increased risk. Ph.D., 19-12-2014. Promotor: von Birgelen C.
K. Tandjung. Clinical assessment of drug-eluting stents: TWENTE trial and beyond. Ph.D. (cum laude), 25-06-2014. Promotor: von Birgelen C.
M.A.G.M. Olimulder. Utility of cardiovascular magnetic resonance imaging with contrast- enhancement beyond the scope of viability. Ph.D., 25-06-2014. Promotor: von Birgelen C.
M.G. Stoel. Angiography and coronary function – a clinical approach. Ph.D., 11-10-2013. Promotors: von Birgelen C. and Zijlstra F.
M.W.Z. Basalus. Drug-eluting stents: from bench-top to clinical research. Ph.D., 11-10-2013. Promotor: von Birgelen C.
M. Hartmann. Serial intravascular ultrasound assessment of coronary atherosclerosis progression and remodeling. Ph.D., 27-11-2008. Promotor: von Birgelen C.
Scan de QR-code of